Why is Ind-Swift Labs. falling/rising?

As of 07-Jul, Ind-Swift Laboratories Ltd is experiencing a price increase, currently at Rs 119.60, reflecting a rise of 5.35 or 4.68%. The stock has shown strong performance today, outperforming its sector by 4.76% and opening with a gain of 3.24%. It reached an intraday high of Rs 121, and is trading above all key moving averages, indicating positive momentum. Over the past week, the stock has risen by 6.79%, and in the last month, it has surged by 29.02%. However, despite these gains, the stock has faced challenges, including a significant drop in delivery volume and a high Debt to EBITDA ratio, which raises concerns about its long-term financial health. Additionally, while institutional investors have increased their stake, the company has not declared results in the last six months, which could affect investor confidence.
Broader market context shows that while Ind-Swift Laboratories Ltd has outperformed the Sensex in the short term, with a 1-week return of 6.79% compared to the benchmark's -0.20%, it has underperformed over the past year, with a return of -10.04% against the Sensex's 4.31%. This disparity highlights the stock's volatility and the mixed signals it presents to investors. The overall market has generated positive returns, contrasting with the company's recent negative performance, which may lead to cautious sentiment among potential investors despite the recent price rise.